From: The mode of progressive disease affects the prognosis of patients with metastatic breast cancer
n = 107 | No |
---|---|
Age, years | |
< 50 | 20 |
50–59 | 38 |
≥ 60 | 49 |
Menopausal status | |
Premenopausal | 22 |
Postmenopausal | 85 |
T factor | |
T1 | 15 |
T2 | 43 |
T3 | 7 |
T4 | 20 |
Unknown | 22 |
Nodal status | |
N (−) | 19 |
N (+) | 74 |
Unknown | 14 |
Subtypes | |
Luminal A/B | 68 |
Luminal HER2 | 8 |
HER2 | 14 |
Triple negative | 17 |
Metastatic sites | |
Bone | 61 |
Lung | 34 |
Liver | 29 |
Lymph node | 44 |
Pleural | 26 |
Local | 15 |
Brain | 9 |
Others | 8 |